To comprehend the feasibility of the inhibitor of tyrosine phosphatase pervanadate using for therapy of radiation injury and inquire into the effects of tyrosine phosphatases on the radiation injury of hematopoietic cells, the effects of different times of administration on NFS-60 cells irradiated with different doses were observed. It was found that pervanadate could specifically enhance the proliferation of irradiated cells, such effects became obvious with the dose of irradiation increased and displayed time effects. For 3Gy irradiated NFS-60 cells, good results were achieved when pervanadate was administrated 24h after irradiation, there were no difference between before and 30 mins after irradiation, but for 5Gy irradiated cells, the best time administration is 24 and 48h after irradiation. Effects of pervanadate administrated before irradiation was better than that administrated 30min after irradiation. These results suggest that protein tyrosine phosphatase might involve in the course of radiation injury of hematopoietic cells. It is hoped that enhancing receptor signal transduction by PTP inhibitors will become a new way of therapy of acute radiation disease.